Literature DB >> 10720087

Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects.

J M Fernández-Real1, M Broch, J Vendrell, C Richart, W Ricart.   

Abstract

Several lines of evidence indicate that interleukin-6 (IL-6) is involved not only in the hepatic acute phase response but also in adipose tissue metabolism, lipoprotein lipase activity, and hepatic triglyceride secretion. A polymorphism in the IL-6 gene, associated with differences in IL-6 transcription rate, has been recently described. We aimed to study whether this IL-6 gene polymorphism leads to differences in fasting and postglucose load plasma lipids in healthy subjects. Subjects with G at position -174 of the IL-6 gene were similar in age, sex, body mass index, and waist to hip ratio in comparison with carriers of the C allele. However, G carriers showed almost twice plasma triglycerides (1.5 +/- 0.9 vs. 0.90 +/- 0.37 mmol/L; P = 0.01), very low-density lipoprotein (VLDL)-triglycerides (0.97 +/- 0.69 vs. 0.42 +/- 0.2 mmol/L; P = 0.002), higher fasting (881 vs. 458 micromol/L; P = 0.01), and postglucose load free fatty acids (299 vs. 90.5 micromol/L; P = 0.03), slightly lower high-density lipoprotein-2 cholesterol (0.25 +/- 0.14 vs. 0.39 +/- 0.26 mmol/L; P = 0.058), and similar cholesterol and LDL-cholesterol levels than carriers of the C allele. Serum IL-6 levels correlated positively with fasting triglycerides, VLDL-triglycerides, and postload free fatty acids (r = 0.61, 0.65 and 0.60, respectively; P < 0.001) and negatively with high-density lipoprotein-cholesterol (r = -0.42, P < 0.05). A tendency toward higher serum IL-6 levels was observed among G carriers (9.9 +/- 6.9 vs. 6.85 +/- 1.7 pg/mL; P = 0.09). The -174G construct was recently reported to show higher expression of IL-6 in He La cells and was associated with higher plasma IL-6 levels than the -174C allele. Thus, the results of the present study suggest that subjects with the G allele, associated to higher IL-6 secretion, are prone to lipid abnormalities. Whether this polymorphism contributes to lipid alterations associated with other metabolic disorders awaits additional studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720087     DOI: 10.1210/jcem.85.3.6555

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  52 in total

1.  Genetic determinants of IL-6 expression levels do not influence bone loss in inflammatory bowel disease.

Authors:  C Schulte; H Goebell; H D Röher; K M Schulte
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

2.  Factors Associated With Plasma IL-6 Levels During HIV Infection.

Authors:  Álvaro H Borges; Jemma L O'Connor; Andrew N Phillips; Frederikke F Rönsholt; Sarah Pett; Michael J Vjecha; Martyn A French; Jens D Lundgren
Journal:  J Infect Dis       Date:  2015-02-26       Impact factor: 5.226

3.  The impact of interleukin-6 promoter -597/-572/-174genotype on interleukin-6 production after lipopolysaccharide stimulation.

Authors:  M Müller-Steinhardt; B Ebel; C Härtel
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

4.  Il6 gene promoter polymorphism (-174G/C) influences the association between fat mass and cardiovascular risk factors.

Authors:  A Moleres; T Rendo-Urteaga; C Azcona; J A Martínez; S Gómez-Martínez; J R Ruiz; L A Moreno; A Marcos; A Marti
Journal:  J Physiol Biochem       Date:  2009-12       Impact factor: 4.158

5.  Role of interleukin-6 as an early marker of fat embolism syndrome: a clinical study.

Authors:  Shiva Prakash; Ramesh Kumar Sen; Sujit Kumar Tripathy; Indu Mohini Sen; R R Sharma; Sadhna Sharma
Journal:  Clin Orthop Relat Res       Date:  2013-02-20       Impact factor: 4.176

6.  Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population.

Authors:  Indranil Banerjee; Umeshwar Pandey; Omer M Hasan; Rashmi Parihar; Vijaya Tripathi; Subramaniam Ganesh
Journal:  J Thromb Thrombolysis       Date:  2007-12-23       Impact factor: 2.300

7.  Implications of genetic polymorphisms in inflammation-induced atherosclerosis.

Authors:  Jayashree Shanker; Vijay V Kakkar
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

8.  The relationship of the interleukin-6 -174 G>C gene polymorphism with oxidative stress markers in Turkish polycystic ovary syndrome patients.

Authors:  M Erdogan; M Karadeniz; A Berdeli; G Alper; O Caglayan; C Yilmaz
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

9.  The (-174) G/C polymorphism in the interleukin-6 gene is associated with risk of papillary thyroid carcinoma in Turkish patients.

Authors:  A G Ozgen; M Karadeniz; M Erdogan; A Berdeli; F Saygili; C Yilmaz
Journal:  J Endocrinol Invest       Date:  2009-04-15       Impact factor: 4.256

10.  Interleukin-6 as an early marker for fat embolism.

Authors:  R Yoga; Jc Theis; M Walton; W Sutherland
Journal:  J Orthop Surg Res       Date:  2009-06-13       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.